These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 24423116)

  • 21. Engineering T cells for cancer: our synthetic future.
    Vonderheide RH; June CH
    Immunol Rev; 2014 Jan; 257(1):7-13. PubMed ID: 24329786
    [No Abstract]   [Full Text] [Related]  

  • 22. New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies.
    Schmitt TM; Stromnes IM; Chapuis AG; Greenberg PD
    Clin Cancer Res; 2015 Dec; 21(23):5191-7. PubMed ID: 26463711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TCR repertoires of intratumoral T-cell subsets.
    Linnemann C; Mezzadra R; Schumacher TN
    Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive T Cell Therapy: New Avenues Leading to Safe Targets and Powerful Allies.
    Hammerl D; Rieder D; Martens JWM; Trajanoski Z; Debets R
    Trends Immunol; 2018 Nov; 39(11):921-936. PubMed ID: 30309702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cell-based artificial antigen-presenting cells for cancer immunotherapy.
    Butler MO; Hirano N
    Immunol Rev; 2014 Jan; 257(1):191-209. PubMed ID: 24329798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.
    Chung DS; Shin HJ; Hong YK
    J Immunol Res; 2014; 2014():326545. PubMed ID: 25009822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo gene transfer for improved adoptive immunotherapy of cancer.
    Ngo MC; Rooney CM; Howard JM; Heslop HE
    Hum Mol Genet; 2011 Apr; 20(R1):R93-9. PubMed ID: 21415041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy.
    Bobisse S; Zanovello P; Rosato A
    Expert Opin Biol Ther; 2007 Jun; 7(6):893-906. PubMed ID: 17555374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy and gene therapy.
    Simpson E
    IDrugs; 2004 Feb; 7(2):105-8. PubMed ID: 15057648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors.
    Leuci V; Mesiano G; Gammaitoni L; Aglietta M; Sangiolo D
    Curr Gene Ther; 2014 Feb; 14(1):52-62. PubMed ID: 24365144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene Therapy.
    Hinrichs CS
    Clin Cancer Res; 2016 Apr; 22(7):1559-64. PubMed ID: 27037253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.
    Morgan MA; Büning H; Sauer M; Schambach A
    Front Immunol; 2020; 11():1965. PubMed ID: 32903482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and development of therapies using chimeric antigen receptor-expressing T cells.
    Dotti G; Gottschalk S; Savoldo B; Brenner MK
    Immunol Rev; 2014 Jan; 257(1):107-26. PubMed ID: 24329793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors.
    Eom HS; Choi BK; Lee Y; Lee H; Yun T; Kim YH; Lee JJ; Kwon BS
    J Immunother; 2016 Apr; 39(3):140-8. PubMed ID: 26938947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
    Deniger DC; Maiti SN; Mi T; Switzer KC; Ramachandran V; Hurton LV; Ang S; Olivares S; Rabinovich BA; Huls MH; Lee DA; Bast RC; Champlin RE; Cooper LJ
    Clin Cancer Res; 2014 Nov; 20(22):5708-19. PubMed ID: 24833662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAR T Cell Therapy for Neuroblastoma.
    Richards RM; Sotillo E; Majzner RG
    Front Immunol; 2018; 9():2380. PubMed ID: 30459759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy.
    Maus MV; June CH
    Clin Cancer Res; 2016 Apr; 22(8):1875-84. PubMed ID: 27084741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adoptive immunotherapy utilizing cancer antigen-specific T-cell receptors].
    Tanimoto K; Fujiwara H
    Rinsho Ketsueki; 2016; 57(11):2355-2364. PubMed ID: 27941286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies.
    Marr LA; Gilham DE; Campbell JD; Fraser AR
    Clin Exp Immunol; 2012 Feb; 167(2):216-25. PubMed ID: 22235997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies.
    Chen L; Dong L; Ma Y; Wang J; Qiao D; Tian G; Wang M
    BMC Immunol; 2021 Sep; 22(1):65. PubMed ID: 34583647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.